Morgan Stanley (NYSE:MS) Price Target Raised to $205.00 at BNP Paribas Exane

Morgan Stanley (NYSE:MS) had its price objective upped by equities researchers at BNP Paribas Exane from $195.00 to $205.00 in a research note issued on Friday,MarketScreener reports. The firm presently has a “neutral” rating on the financial services provider’s stock. BNP Paribas Exane’s price target would indicate a potential upside of 9.01% from the company’s previous close.

Several other equities analysts have also recently weighed in on MS. Erste Group Bank reissued a “hold” rating on shares of Morgan Stanley in a report on Thursday, March 5th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $207.00 target price on shares of Morgan Stanley in a report on Thursday, April 16th. Daiwa Securities Group decreased their target price on Morgan Stanley from $187.00 to $175.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Morgan Stanley in a report on Thursday, January 22nd. Finally, Wells Fargo & Company raised their target price on Morgan Stanley from $189.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, April 16th. Ten research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $201.89.

Morgan Stanley Stock Performance

Shares of NYSE MS traded down $0.60 during midday trading on Friday, hitting $188.05. 308,123 shares of the stock traded hands, compared to its average volume of 7,196,028. The firm has a 50-day moving average of $169.91 and a two-hundred day moving average of $171.58. The firm has a market capitalization of $297.38 billion, a P/E ratio of 17.04, a PEG ratio of 1.44 and a beta of 1.19. The company has a debt-to-equity ratio of 3.39, a quick ratio of 0.81 and a current ratio of 0.81. Morgan Stanley has a one year low of $112.03 and a one year high of $194.59.

Morgan Stanley (NYSE:MS) last released its quarterly earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.02 by $0.41. The firm had revenue of $20.58 billion for the quarter, compared to analysts’ expectations of $19.23 billion. Morgan Stanley had a return on equity of 17.89% and a net margin of 14.65%.The company’s revenue was up 16.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.60 EPS. On average, equities analysts forecast that Morgan Stanley will post 11.8 EPS for the current fiscal year.

Insider Buying and Selling at Morgan Stanley

In other Morgan Stanley news, insider Daniel A. Simkowitz sold 14,690 shares of the firm’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the sale, the insider directly owned 365,802 shares of the company’s stock, valued at $69,224,370.48. This trade represents a 3.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Andrew M. Saperstein sold 51,668 shares of the firm’s stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $188.59, for a total value of $9,744,068.12. Following the sale, the insider directly owned 282,142 shares in the company, valued at approximately $53,209,159.78. This represents a 15.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 110,444 shares of company stock valued at $20,665,049 over the last ninety days. 0.17% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MS. Purpose Unlimited Inc. purchased a new position in shares of Morgan Stanley during the fourth quarter valued at about $25,000. Motiv8 Investments LLC purchased a new position in shares of Morgan Stanley during the fourth quarter valued at about $25,000. Olistico Wealth LLC purchased a new position in shares of Morgan Stanley during the fourth quarter valued at about $27,000. Lodestone Wealth Management LLC purchased a new position in shares of Morgan Stanley during the fourth quarter valued at about $28,000. Finally, WFA of San Diego LLC purchased a new position in shares of Morgan Stanley during the second quarter valued at about $28,000. Hedge funds and other institutional investors own 84.19% of the company’s stock.

Key Stories Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley’s Investment Management launched a Stablecoin Reserves Portfolio (MSNXX) that lets stablecoin issuers park reserves in a Morgan Stanley money‑market fund (minimum $10M). This expands fee-bearing institutional product offerings in digital assets and positions MS as a trusted custodian/partner for crypto infrastructure. Morgan Stanley launches stablecoin offering through money market fund
• Positive Sentiment: Institutional crypto flows are benefiting Morgan Stanley’s asset-management franchise: the bank’s bitcoin ETF (MSBT) has seen meaningful early inflows and reports note a large institutional allocation (~$138M referenced in market coverage). That supports AUM growth and fee revenue. $138M Bitcoin Play Triggers Rally
• Neutral Sentiment: NZX accredited Morgan Stanley as a clearing participant for its derivatives market ahead of new S&P/NZX 20 futures — a niche expansion in derivatives clearing that broadens MS’s institutional footprint but is unlikely to move near-term earnings materially. NZX Adds Morgan Stanley as Clearing Participant
• Neutral Sentiment: Analyst/market commentary (Zacks, MarketBeat pieces) highlight Morgan Stanley’s capital‑markets strength and wealth‑management push — favorable for longer‑term growth — while noting execution risks; these notes help sentiment but are not fresh company disclosures. The Zacks Analyst Blog UnitedHealth, Morgan Stanley, RTX, Homes Group and Motorsport
• Negative Sentiment: Macro and internal notes raise caution: Morgan Stanley commentary on GDP/outlook and analyst mentions of rising expenses and trading volatility suggest pressure on trading revenues and margins if market activity softens — a headwind for short‑term profitability. Morgan Stanley drops stunning take on GDP outlook

About Morgan Stanley

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.